Hypovolemic shock is a critical condition characterized by inadequate tissue perfusion due to a significant loss of blood or fluids. It is a common cause of shock in pediatric patients and requires prompt recognition and intervention to prevent morbidity and mortality. This article provides an overview of the epidemiology, etiology, pathogenesis, pathophysiology, clinical features, differential diagnosis, diagnosis, treatment, and potential complications of hypovolemic shock in infants and children, tailored for pediatric residents.
Epidemiology
Hypovolemic shock is the most common type of shock in children, accounting for a significant proportion of pediatric emergency department visits and hospital admissions. It can occur at any age but is particularly prevalent in infants and young children due to their higher susceptibility to dehydration and fluid losses. The incidence varies globally, with higher rates in regions with limited access to healthcare and higher prevalence of infectious diseases.
Etiology
The causes of hypovolemic shock in children can be broadly categorized into:
Pathogenesis and pathophysiology
The pathogenesis of hypovolemic shock involves a critical reduction in circulating blood volume, leading to decreased venous return to the heart and reduced cardiac output. This triggers a cascade of compensatory mechanisms aimed at maintaining perfusion to vital organs:
- Tachycardia to increase cardiac output. Remember, cardiac output is calculated as (stroke volume x heart rate).
- Stroke volume is determined by multiple things:
- Preload (which is abnormally low in hypovolemic shock),
- Contractility (which is abnormally low in cardiogenic shock)
- Afterload (which is abnormal in distributive shock).
- Stroke volume is determined by multiple things:
- Peripheral vasoconstriction to increase systemic vascular resistance and maintain blood pressure.
- Increased respiratory rate to enhance oxygen delivery.
- Persistent hypoperfusion leads to cellular hypoxia and metabolic acidosis.
- Organ dysfunction ensues, with potential progression to multi-organ failure.
- Prolonged hypoperfusion results in irreversible cellular damage and death.
Clinical features
Differential diagnosis involves distinguishing hypovolemic shock from other types of shock and conditions with similar presentations:
Differential diagnosis
Differential diagnosis involves distinguishing hypovolemic shock from other types of shock and conditions with similar presentations:
- History of congenital heart disease or myocarditis.
- Signs of heart failure:
- Hepatomegaly.
- Gallop rhythm.
- Cardiomegaly on chest X-ray.
- Septic shock:
- Fever.
- Signs of infection.
- Bounding pulses.
- Brisk capillary refill.
- Anaphylactic shock:
- History of allergen exposure.
- Urticaria.
- Respiratory distress.
- Vomiting.
- Skin findings.
- Angioedema.
- Adrenal crisis:
- Chronic steroid use.
- History of adrenal insufficiency.
- Lack of response to inotropes.
- Tension pneumothorax:
- Absent breath sounds.
- Tracheal deviation.
- Cardiac tamponade:
- Muffled heart sounds.
- Pulsus paradoxus (larger than expected drop, >10, in systolic blood pressure during inhalation).
Diagnosis
Diagnosis of hypovolemic shock involves a combination of clinical assessment, laboratory tests, and imaging:
- Detailed history and physical examination.
- Assessment of vital signs, perfusion status, and mental state.
- Complete blood count (CBC) to assess hemoglobin and hematocrit levels.
- Electrolytes and renal/liver function tests to assess for end organ damage.
- Blood gas analysis to evaluate acid-base status.
- Lactate: At the cellular level the lack of oxygen to the cells leads to an interruption of oxidative phosphorylation that shifts the body into anaerobic metabolism, thus depleting ATP and increasing lactic acid production.
- Chest X-ray to rule out pulmonary causes of shock.
- Abdominal ultrasound or CT scan to identify sources of bleeding or third spacing.
Treatment
Treatment of hypovolemic shock focuses on rapid restoration of circulating volume and addressing the underlying cause:
- Isotonic crystalloids (e.g., normal saline, lactated Ringer’s) are the first-line treatment. Trial of two boluses of isotonic fluids is often done prior to initiating inotropic support.
- Albumin can be used in situations where there is presumed direct protein loss, such as burns or protein losing enteropathies.
- Blood transfusion for hemorrhagic shock with significant blood loss. If large volumes of RBCs are given, you will need to give FFP and platelets also.
Inotropic agents (e.g., dopamine, epinephrine) for persistent hypotension despite adequate fluid resuscitation.
- Oxygen therapy to maintain adequate oxygenation.
- Monitoring of vital signs, urine output, and laboratory parameters.
- Surgical intervention for trauma or gastrointestinal bleeding.
- Management of underlying conditions (e.g., insulin therapy for diabetic ketoacidosis, antibiotics for concurrent infection, stress dose steroids for adrenal crisis).
Potential complications
Complications of hypovolemic shock can arise from both the condition itself and its treatment:
- Acute kidney injury.
- Disseminated intravascular coagulation (DIC).
- Acute respiratory distress syndrome (ARDS).
- Acute liver injury.
- Neurological deficits due to prolonged hypoxia.
- Chronic renal impairment requiring dialysis.
Conclusion
Hypovolemic shock in infants and children is a life-threatening condition that requires prompt recognition and aggressive management. Understanding the epidemiology, etiology, pathogenesis, pathophysiology, clinical features, differential diagnosis, diagnosis, treatment, and potential complications is essential for pediatric residents to provide optimal care. Early intervention can significantly improve outcomes and reduce the risk of complications.
Image credits
Unless otherwise noted, images are from Adobe Stock.